Author(s):
Pattilthodika Suhail, Velappan Venkatachalam Venkatachalam, Sanal Dev, Radhakrishnan Murali, Arvind Babu Lalpet Renganathan
Email(s):
ptsuhl@gmail.com
DOI:
10.52711/0974-360X.2025.00383 
Address:
Pattilthodika Suhail1*, Velappan Venkatachalam Venkatachalam2, Sanal Dev3, Radhakrishnan Murali2, Arvind Babu Lalpet Renganathan4
1Department of Pharmacology, Al Shifa College of Pharmacy, Affiliated to KUHS, Perinthalmanna, Kerala.
2Department of Pharmacy, Annamalai University, Annamalai Nagar, Chidambaram, Tamilnadu.
3Department of Pharmaceutical Chemistry, Al Shifa College of Pharmacy, Affiliated to KUHS, Perinthalmanna, Kerala.
4Department of Computer Science, Annamalai University, Annamalai Nagar, Chidambaram, Tamilnadu.
*Corresponding Author
Published In:
Volume - 18,
Issue - 6,
Year - 2025
ABSTRACT:
The oxazaphosphorine alkylating drugs, cyclophosphamide and its structural isomer, ifosamide, are frequently employed in the field of oncology for cancer treatment and immunosuppression purposes. An effective treatment method against cyclophosphamide toxicity has been suggested using plant extracts with high levels of antioxidant constituents. This study evaluates in vitro anticancer activity and anticipates the potential of quinic acid from A. muricata fruit to impact cyclophosphamide metabolism using CYP 450 isoenzyme inhibition. The phytochemicals in the ethanolic extract of A. muricata fruit were initially identified and validated using Q-TOF LC-MS. The MTT assay, a widely used method in cancer research, was employed to assess the potential anticancer activity against MCF-7 cancer cell lines in an in vitro setting. In molecular docking, one of the isolated compounds, quinic acid, was therefore indented to be docked with CYP-450 proteins. In Q-TOF LC/MS analysis, the different peaks were obtained at different retention times, and the quinic acid was at the retention time of 3.1 minutes. The extract showed remarkable in vitro anticancer activity (IC50 value of 240.709 µg/mL) against MCF-7 cancer cell lines. The molecular docking study showed the most effective inhibition on CYP 3A4, CYP 2D6, CYP 2B6 and CYP 2C9 proteins, which indicated the interaction of quinic acid with CYP proteins and herbal drug interaction.
Cite this article:
Pattilthodika Suhail, Velappan Venkatachalam Venkatachalam, Sanal Dev, Radhakrishnan Murali, Arvind Babu Lalpet Renganathan. Quinic acid from Annona muricata Fruit Inhibits Cyclophosphamide Metabolism through Modulation of Cytochrome P450: Implications for Herbal-Drug Interaction. Research Journal of Pharmacy and Technology. 2025;18(6):2664-9. doi: 10.52711/0974-360X.2025.00383
Cite(Electronic):
Pattilthodika Suhail, Velappan Venkatachalam Venkatachalam, Sanal Dev, Radhakrishnan Murali, Arvind Babu Lalpet Renganathan. Quinic acid from Annona muricata Fruit Inhibits Cyclophosphamide Metabolism through Modulation of Cytochrome P450: Implications for Herbal-Drug Interaction. Research Journal of Pharmacy and Technology. 2025;18(6):2664-9. doi: 10.52711/0974-360X.2025.00383 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-6-36
REFERENCES:
1. Gupta N, Agrawal RC, Shrivastava V, Roy A, Prasad P. Aegle marmelos fruit extract prevents cyclophosphamide induced micronucleus formation in mice. Research Journal of Pharmacy and Technology. 2011; 4(11): 1794-996.
2. D. Benito Johnson, Faisal Mohammad Ali Abdalla, Abdulaziz. Evaluation of the Chemoprotective Activity of 70% Methanolic Extract of Gmelina arborea Stem Bark against Cyclophosphamide Induced Toxicity. Research J. Pharm. and Tech. 2014; 7(12): Dec. 1420-1428.
3. Mohammad Ali Roozegar, Hassan Nourmohammadi, Mohammadreza Havasian, Hossein Seidkhani, Solmaz Jamdar. Evaluation of Oral and Dental complications caused by Cyclophosphamide in patients with breast cancer in the Shahid-Mostafa Hospital, Ilam, 2019. Research Journal of Pharmacy and Technology. 2022; 15(12): 5517-0.
4. Shantilal Singune, Jai S Vaghela. Investigation of Immunomodulatory Activity of Methanolic Extract and Isolated Compound of Pavonia odorata Roots in Mice. Research Journal of Pharmacy and Technology. 2021; 14(7): 3489-4.
5. Jawnaa K. Mammdoh, Rana KA Attarbashee, Alhan DH Al mola. Protective effect of rosuvastatin on cyclophosphamide-induced oral toxicity in rats: Histological and immunohistochemical Study. Research Journal of Pharmacy and Technology 2023; 16(2):759-2.
6. Zahraa Zuhair Alsaidi, Haider H. Humaish, Amer Alasadi. Toxic effects of Cyclophosphamide on Hepatic and Kidney tissues in Albino Mice Model. Research Journal of Pharmacy and Technology. 2022; 15(10): 4655-9.
7. Palaksha M. N., Ravishankar K, Vijaya Nandini. Evaluation of the Immunomodulatory Effect of Eclipta prostrata whole Plant Extract on Albino Rats. Res. J. Pharmacology and Pharmacodynamics. 2017; 9(2): 41-45.
8. Dingemanse J, Cruz HG, Gehin M, Hoever P. Pharmacokinetic interactions between the orexin receptor antagonist almorexant and the CYP3A4 inhibitors ketoconazole and diltiazem. Journal of Pharmaceutical Sciences. 2014; May 1; 103(5): 1548-56. https://doi.org/10.1002/jps.23916
9. Wanwimolruk S, Prachayasittikul V. Cytochrome P450 enzyme mediated herbal drug interactions (Part 1). EXCLI journal. 2014; 13: 347.
10. Ahmad Ainurofiq, Lutvi Ismaya. Pharmacokinetic Drug-Drug Interactions: A Systematic Review of the Cytochrome P450 (CYP) Isoenzyme 3A4. Research Journal of Pharmacy and Technology. 2023; 16(6): 3016-4.
11. Syed Safiullah Ghori, Ayesha Ruqsar, Mohammed Akram, Zehra Fatima,Mir Iftekhar Ali Arafath. Evaluation of Immunomodulatory activity of Ficus dalhousiae Miq leaves Methanolic extract against Cyclophosphamide Induced Myelosuppression. Research J. Pharm. and Tech. 2018; 11(8): 3427-3430.
12. Kumar KB, Kuttan R. Chemoprotective activity of an extract of Phyllanthus amarus against cyclophosphamide induced toxicity in mice. Phytomedicine. 2005; Jun 15; 12(6-7):494-500. https://doi.org/10.1016/j.phymed.2004.03.009
13. Yang M, Li J, Zhao C, Xiao H, Fang X, Zheng J. LC-Q-TOF-MS/MS detection of food flavonoids: Principle, methodology, and applications. CritiCal reviews in Food sCienCe and nutrition. 2023; Jul 26; 63(19): 3750-70. https://doi.org/10.1080/10408398.2021.1993128
14. Sánchez-Hernández E, González-García V, Palacio-Bielsa A, Casanova-Gascón J, Navas-Gracia LM, Martín-Gil J, Martín-Ramos P. Phytochemical Constituents and Antimicrobial Activity of Euphorbia serrata L. Extracts for Borago officinalis L. Crop Protection. Horticulturae. 2023; Jun 1; 9(6): 652. https://doi.org/10.3390/horticulturae9060652
15. Anastasius N, Boston S, Lacey M, Storing N, Whitehead SA. Evidence that low-dose, long-term genistein treatment inhibits oestradiol-stimulated growth in MCF-7 cells by down-regulation of the PI3-kinase/Akt signalling pathway. J Steroid Biochem Mol Biol. 2009; 116(1–2): 50–5. https://doi.org/10.1016/j.jsbmb.2009.04.009
16. Sarvesh Sabarathinam, T M Vijayakumar. RP-HPLC Method Development and Validation of Midazolam: A CYP3A4 Probe Drug. Research J. Pharm. and Tech. 2020; 13(8): 3565-3568.
17. Neeraj Upmanyu, Surya Gupta, B N Prakash, Gopal Garg , P Mishra. Cheminformatics: A New Approach. Research J. Pharm. and Tech. 2008; 1(1): Jan.-Mar. 2-5.
18. Kriegl JM, Eriksson L, Arnhold T, Beck B, Johansson E, Fox T. Multivariate modeling of cytochrome P450 3A4 inhibition. European Journal of Pharmaceutical Sciences. 2005 Apr 1; 24(5): 451-63. https://doi.org/10.1016/j.ejps.2004.12.009
19. Shiraga T, Matsuda H, Nagase K, Iwasaki K, Noda K, Yamazaki H, Shimada T, Funae Y. Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes. Biochemical Pharmacology. 1994; Feb 11; 47(4): 727-35. https://doi.org/10.1016/0006-2952(94)90136-8
20. Turpeinen M, Nieminen R, Juntunen T, Taavitsainen P, Raunio H, Pelkonen O. Selective inhibition of CYP2B6-catalyzed bupropion hydroxylation in human liver microsomes in vitro. Drug Metabolism and Disposition. 2004; Jun 1; 32(6): 626-31. https://doi.org/10.1124/dmd.32.6.626
21. Goodwin B, Moore LB, Stoltz CM, McKee DD, Kliewer SA. Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor. Molecular Pharmacology. 2001; Sep 1; 60(3): 427-31.
22. Wang H, Negishi M. Transcriptional regulation of cytochrome p450 2B genes by nuclear receptors. Current Drug Metabolism. 2003; Dec 1; 4(6): 515-25. https://doi.org/10.2174/1389200033489262
23. Yasuo K, Yamaotsu N, Gouda H, Tsujishita H, Hirono S. Structure-based CoMFA as a predictive model-CYP2C9 inhibitors as a test case. Journal of Chemical Information and Modeling. 2009; Apr 27; 49(4): 853-64. https://doi.org/10.1021/ci800313h
24. Gleeson MP, Davis AM, Chohan KK, Paine SW, Boyer S, Gavaghan CL, Arnby CH, Kankkonen C, Albertson N. Generation of in-silico cytochrome P450 1A2, 2C9, 2C19, 2D6, and 3A4 inhibition QSAR models. Journal of Computer-aided Molecular Design. 2007; Oct; 21: 559-73.